ESG Data

Environment

You can see this table by scrolling horizontally.

Aspect Classification Scope Unit FY2017
*1		 FY2018
*1		 FY2019
*1
CO2 Emissions
(SCOPE1+2)		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t-CO2 249,497 234,540 49,829
Outside Japan t-CO2 115,773 123,676 2,658
Global t-CO2 365,270 358,216 52,487
Emissions
year-on-year
(SCOPE1+2)
 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan % 0.1 -6.0 -78.8
Outside Japan % 1.0 6.8 -97.9
Global % 0.4 -1.9 -85.3
Unit CO2
emissions		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 Global t-CO2
/billion
yen-
Sales revenue		 103 103 17.2
Emissions
(SCOPE1)		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t-CO2 37,913 37,648 16,849
Outside Japan t-CO2 30,798 30,378 396
Global t-CO2 68,711 68,027 17,244
Emissions
(SCOPE2)　　		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t-CO2 211,584 196,892 32,980
Outside Japan t-CO2 84,975 93,297 2,262
Global t-CO2 296,559 290,189 35,242
Emissions
(SCOPE3)
  1. *
    Category11,14 and 15 are not applicable.
 Category1:
Purchased
goods and
services		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t-CO2 133,558 134,563 1,340
Outside Japan t-CO2 33,678 35,011 1,040
Global t-CO2 167,236 169,574 2,379
Category2:
Capital goods		 Pharmaceuticals Business*3 In Japan t-CO2 - - 27,539
Outside Japan t-CO2 - - 336
Global t-CO2 - - 27,891
Category3:
Fuel and energy related activities not included in Scope 1 or 2		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t-CO2 - 33,813 6,038
Outside Japan t-CO2 - 15,519 304
Global t-CO2 - 49,332 6,343
Category4:
Transportation
and delivery
(upstream)		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t-CO2 19,127 19,542 236
Outside Japan t-CO2 5,077 6,164 40
Global t-CO2 24,025 25,706 276
Category5:
Waste generated
erati in opons		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t-CO2 15,773 16,364 777
Outside Japan t-CO2 5,140 10,420 63
Global t-CO2 20,913 26,766 840
Category6:
Business travel		 Pharmaceuticals Business*3 In Japan t-CO2 - - 861
Category7:
Employee commuting		 Pharmaceuticals Business*3 In Japan t-CO2 - - 2,446
Category8:
Leased assets (upstream)		 Pharmaceuticals Business*5 In Japan t-CO2 - - 2,402
Category13:
Leased assets (downstream)		 Pharmaceuticals Business*3 Global t-CO2 - - 2,059
Emissions
(on each site)
*Data of major
sites in Japan
are listed
below as
"Site data".　　　　　　　　　　　		 Kyowa Iryo Kaihatsu Co., Ltd. In Japan t-CO2 - - 825
Kyowa Kirin China Pharmaceutical Co., Ltd. Outside Japan t-CO2 2,131 1,912 2,018
Kyowa Kirin, Inc. Outside Japan t-CO2 - - 640
Energy*2 Energy
consumption		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 Global GJ 6,086,607 6,014,225 1,023,310
Energy
consumption
year-on-year		 Global % 1.0 -1.2 -83.0
Unit energy
consumption		 Global GJ/billion
yen-
Sales revenue		 1,722 1,736 335
Electricity Global 1,000kWh 292,916 292,311 70,878
City gas Global 1,000m3 24,160 23,124 5,988
LPG Global t 386 0 0
Heavy oil Global kL 4,979 6,030 84
Kerosene Global kL 1,423 1,355 1,272
Diesel oil Global kL 0.033 20.7 2.88
Steam  Global GJ 1,925,312 1,885,777 7,197
Renewable energy Photovoltaic power generation Pharmaceuticals Business*3 In Japan 1,000kWh 140 132*6 135*6
Water resources Water used
(Total amount)		 Total amount Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan 1,000m3 42,931 38,641 2,215
Outside Japan 1,000m3 9,602*6 9,862 14
Global 1,000m3 52,553*6 48,503 2,229
Tap water Global 1,000m3 1,773 2,241 281
Industrial water Global 1,000m3 31,829*6 29,330 1,155
Ground water
or others		 Global 1,000m3 18,931 16,933 793
Unit water
used		 Global 1,000m3
/billion
yen-
Sales revenue*3		 14.8 14.0 0.73
Amount
of circulated
water usage		 Global 1,000m3 98,876*6 119,981 22,166
Ratio of
circulated
water usage		 Global % 188*6 247 994
Wastewater Total amount In Japan 1,000m3 41,802 40,555*6 2,001
Outside Japan 1,000m3 9,304 9,193 7
Global 1,000m3 51,106 49,748*6 2,009
Release into sea Global 1,000m3 35,724 35,722 0
Release into rivers Global 1,000m3 13,837 12,490 1,889
Sewage water Global 1,000m3 1,546 1,536 119
Water pollution COD Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t 228 239 632
Outside Japan t 1007 697 0.0
Global t 1,234 936 632
Total nitrogen In Japan t 298 247 5.6
Outside Japan t 683 608 0.0
Global t 981 855 5.6
Total
phosphorus		 In Japan t 16 12 1.5
Outside Japan t - - 0.0
Global t 16 12 1.5
Material Raw material
consumption		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t 129,910 117,122 166
Outside Japan t 77,101 68,845 9
Global t 207,011 185,967 175
Waste Waste
generated		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t 47,326 34,613 1,160
Outside Japan t 25,620 26,565 16
Global t 72,945 61,178 1,176
External
recycled
waste 		 In Japan t 21,936 22,248 1,142
Outside Japan t 13,703 25,264 0
Global t 36,938 47,512 1,142
Final disposal In Japan t 8.6 1.9 1.1
Outside Japan t 225.3 184.0 16
Global t 233.9 185.9 17
Final disposal
rate		 In Japan % 0.018 0.005 0.091
Outside Japan % 1.0 0.7 6.3
Global % 0.5 0.3 1.4
Basel
Convention
hazardous
wastes		 Global 　 None None None
Air SOx Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t 5.9 7.1 0.3
Outside Japan t 2.0 2.0 0
Global t 8.0 9.1 0.3
Unit SOx emissions Global t/billionyen-Sales revenue 2.3 2.6 0.1
NOx In Japan t 17.1 17.4 6.2
Outside Japan t 11.9 12.8 0
Global t 28.9 30.2 6.2
Unit NOx emissions Global t/billionyen-Sales revenue 8.2 8.7 2.0
Dust In Japan t 0.7 0.8 0.09
Outside Japan t 4.9 5.3 0
Global t 5.5 6.1 0.09
Unit dust emissions Global t/billionyen-Sales revenue 1.6 1.8 0.03
VOC In Japan t 596 481 0.05
Unit VOC emissions Global t/billionyen-Sales revenue 169.0 139 0.01
ODS emissions In Japan t 0.15 0.19 0.005
PRTR Releases into
the air		 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t 61.6 56.9 0.02
Unit releases into the air In Japan t/billionyen-Sales revenue 17.4 16.4 0.01
Releases into
the water		 In Japan t 5.0 5.0 0
Unit releases into the water In Japan t/billionyen-Sales revenue 1.4 1.4 0
Releases into
the soil		 In Japan t 0 0 0
Unit releases into the soil In Japan t/billionyen-Sales revenue 0 0 0
Management ISO14001 certified sites*7 Pharmaceuticals Business*3, Bio-Chemicals Business*4 In Japan Sites 13 12 4
Outside Japan Sites 1 1 0
Global Sites 14 13 4
Ratio of ISO14001 certified sites*7 Global % 82.4 81.3 57.1
Expensive
fines by law
violation		 Global 　 None None None
Site data Unit energy
consumption		 Tokyo Research Park In Japan GJ/m2
-Floor		 2.95 2.71 2.56
CO2 Emissions t 3,354 3,023 2,815
Water used 1,000m3 21 19 18
Wastewater 1,000m3 18 17 16
COD t - - -
Total nitrogen t 0.07 0.06 0.05
Total
phosphorus		 t 0.01 0.00 0.00
Waste
generated		 t 72.4 79.0 58.3
Final disposal t 0.0 0.0 0.0
SOx t 0 0 0
NOx t 0.21 0.20 0.21
Dust t 0 0 0
Unit energy
consumption		 Fuji Research Park / CMC R&D Center In Japan GJ/m2
-Floor		 7.13 5.02 4.69
CO2 Emissions t 22,964 16,489 15,254
Water used 1,000m3 2,636 1,890 1,785
Wastewater 1,000m3 2,272 1,566*6 1,621
COD t 1.22 1.46 1.12
Total nitrogen t 1.93 1.36 1.58
Total
phosphorus		 t 0.17 0.08 0.20
Waste
generated		 t 437 237 162
Final disposal t 0 0.0 0.9
SOx t 0 0 0
NOx t 3.15 2.80 1.77
Dust t 0 0 0
Unit energy
consumption		 Bio Process Research and Development Laboratories / Takasaki Plant In Japan GJ/m2
-Floor		 8.11 8.33 7.18
CO2 Emissions t 22,327 22,659 22,045
Water used 1,000m3 295 315 314
Wastewater 1,000m3 295 315 314
COD t 0.51 0.62 0.54
Total nitrogen t 2.27 2.62 2.37
Total
phosphorus		 t 0.18 0.26 0.30
Waste
generated		 t 371 806 521
Final disposal t 0.8 0.8 0.8
SOx t 0 0 0
NOx t 2.00 2.69 2.63
Dust t 0.03 0.05 0.05
Unit energy
consumption		 Ube Plant In Japan GJ/m2
-Floor		 7.28 6.86 6.61
CO2 Emissions t 9,349 9,239 8,889
Water used 1,000m3 77 78 91.9
Wastewater 1,000m3 ―*8 4.26 43.8
COD t ―*8 0.23 630
Total nitrogen t ―*8 0.00 1.62
Total
phosphorus		 t ―*8 0.00 0.95
Waste
generated		 t 221 287 300
Final disposal t 0.6 0.7 0.7
Sox t 0 0 0
Nox t 1.68 1.70 1.51
Dust t 0 0 0
  1. *1:
    Data is from January to December. Amounts are rounded. As a result, the sum and breakdown of data may not equal the totals.
  2. *2:
    Each CO2 emission factors: ①Fuel CO2 emission factors: "Greenhouse Gas Emissions Calculation and Reporting Manual (Ministry of the Environment/Ministry of Economy, Trade and Industry)" factors. ②Electricity CO2 emission factors: Emission factors published by individual power companies (If none published, Emission factors by country from IEA’s CO2 Emissions from Fuel Combustion for the year in question). Energy conversion factor: "the Act on the Rational Use of Energy" factors.
  3. *3:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd, Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Medex Co., Ltd (excluded from 2018 due to deconsolidation) are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered. We have disclosed the data of Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Kirin, Inc. since 2019.
  4. *4:
    In Japan, the plants and research laboratories of Kyowa Hakko Bio Co., Ltd and Kyowa Pharma Chemical Co., Ltd are covered. Overseas, the plants of BioKyowa Inc., Shanghai Kyowa Amino Acid Co., Ltd., and Thai Kyowa Biotechnologies Co., Ltd. are covered. Due to deconsolidation, 2019 data is excluded.
  5. *5:
    Leased vehicles of Kyowa Kirin Co., Ltd. and Kyowa Medical Promotion Co., Ltd.'s are targeted.
  6. *6:
    Data has been revised as a change of scope and a result of data review.
  7. *7:
    As of May 2018, we have completed the update of the ISO 14001 to the latest standard ISO 14001:2015 on all sites, and January 1 2019, we shifted from the third party certification to the self-declaration.
  8. *8:
    Kyowa Kirin Ube Plant started drainage to the public sewer from 2018. Until 2017, it was drained to Kyowa Hakko Bio Yamaguchi Production Center (Ube) located on the same site.

2020 Target

You can see this table by scrolling horizontally.

2020 Target Classification Scope Unit FY2017
*1		 FY2018
*1		 FY2019
*1
CO2 emissions Global target:Reduce CO2 emissions in 2020 to 15% or less of 1990 level CO2 emissions (SCOPE1+2)*2 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 Global t-CO2 365,270 358,216 330,206
Ratio to 1990 Global % -18.3 -19.9 -26.2
In Japan target: Reduce CO2 emissions in 2020 to 15% or less of 2005 level CO2 emissions (SCOPE1+2)*2 Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t-CO2 249,497 234,540 192,610
Ratio to 2005 In Japan % -7.6 -13.1 -28.6
VOC emissions In Japan target: Reduce VOC emissions in 2020 to 50% or less of 2003 level VOC emissions Pharmaceuticals Business*3,
Bio-Chemicals Business*4		 In Japan t 596 481 314
Ratio to 2003 In Japan % -36.3 -48.5 -66.4
  1. *1:
    Data is from January to December. Amounts are rounded. As a result, the sum and breakdown of data may not equal the totals.
  2. *2:
    Each CO2 emission factors: ①Fuel CO2 emission factors: "Greenhouse Gas Emissions Calculation and Reporting Manual (Ministry of the Environment/Ministry of Economy, Trade and Industry)" factors. ②Electricity CO2 emission factors: Emission factors published by individual power companies (If none published, Emission factors by country from IEA’s CO2 Emissions from Fuel Combustion for the year in question).
  3. *3:
    In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd, Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Medex Co., Ltd (excluded from 2018 due to deconsolidation) are covered. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin, Inc. are covered. We have disclosed the data of Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Kirin, Inc. since 2019.
  4. *4:
    In Japan, the plants and research laboratories of Kyowa Hakko Bio Co., Ltd and Kyowa Pharma Chemical Co., Ltd are covered. Overseas, the plants of BioKyowa Inc., Shanghai Kyowa Amino Acid Co., Ltd., and Thai Kyowa Biotechnologies Co., Ltd. are covered.

Social

You can see this table by scrolling horizontally.

Aspect Classification Items Scope Unit FY2017 FY2018 FY2019
Compliance Number of
reports to
hotline		 　 Covering Japan until 2017, and including overseas from 2018 Cases 29 20 27
Research
and
development		 R&D expenses
 R&D
expenses		 Consoli
dated		 ¥ billion 492 457 535
Rate of R&D
expenses to
net sales		 Consoli
dated		 % 13.9 16.8 17.5
Business
Partners		 Questionnaires
about CSR		 Number of
responded
companies		 Covering Japan until 2018, and including overseas from 2019 Companies 343 440 707
Employees Number of
employees
by region		 In Japan In Japan Persons 5,729 5,269 3,792
Outside
Japan		 In North America Persons 391 424 300
In EMEA Persons 612 678 716
In Asia/Oceania Persons 800 871 459
Consoli dated Consoli
dated		 Persons 7,532 7,242 5,267
Employee
data		 Number of
men
employees		 Non-
consoli
dated		 Persons 2,848 2,768 2,519
Number of
women
employees		 Non-
consoli
dated		 Persons 1,177 1,150 1,100
Total Non-
consoli
dated		 Persons 4,025 3,918 3,619
Number of
temporary
employees		 Non-
consoli
dated		 Persons 124 90 89
Ratio of
temporary
employees		 Non-
consoli
dated		 % 3.0 2.2 2.5
Average
years of
service
(men)		 Non-
consoli
dated		 Years 18.4 18.8 18.0
Average
years of
service
(women)		 Non-
consoli
dated		 Years 17.4 17.4 17.1
Total Non-
consoli
dated		 Years 18.1 18.4 17.7
Average age Non-
consoli
dated		 Age 42.5 42.8 42.4
Average
annual salary		 Non-
consoli
dated		 Yen 8,369,461 8,562,688 8,610,603
The number of
new hires 		 Non-
consoli
dated		 Persons 99 90 168
Average
number of
actual hours worked		 Non-
consoli
dated		 Hours 1,840 1,840 1,840
Full-time staff
turnover rate *1		 Non-
consoli
dated		 % 4.2 4.5 12.7
Full-time
employee turnover rate（voluntary turnover）		 Non-
consoli
dated		 % 1.7 2.4 2.1
Diversity Number of 
disabled employees*2		 In Japan Persons 150 143 115
Ratio of
disabled employees*2		 In Japan % 2.33 2.45 2.59
Number of
women
managers		 Non-
consoli
dated		 Persons 91 101 103
Ratio of
women
managers		 Non-
consoli
dated		 % 7.8 8.9 9.7
Special holiday / leave Men
taking child
care leave		 Non-
consoli
dated		 Persons 6 3 9
Women
taking child
care leave　		 Non-
consoli
dated		 Persons 48 41 42
Total Non-
consoli
dated		 Persons 54 44 51
Reduced work
hour  for
childcare
(men)		 Non-
consoli
dated		 Persons 0 0 0
Reduced work
hour  for
childcare
(women)		 Non-
consoli
dated		 Persons 99 79 81
Total Non-
consoli
dated		 Persons 99 79 81
Numbers
taking
nursing
care leave 　		 Non-
consoli
dated		 Persons 93 56 396
Occupational
health and
safety management*3		 Total annual
hours worked		 In Japan Hours 5,203,240 5,579,750 7,698,205
Accident
frequency rate		 In Japan - 0.19 0.36 0.13
Accident
severity rate		 In Japan - 0.005 0.011 0.0062
Number of
fatalities		 Employees Persons 0 0 0
Contractors Persons 0 0 0
Number of
participants
in safety
manager training *4		 In Japan Persons 37 36 23
Rate of
participation
in a labor
union		   In Japan % 100 100 100
Shareholders Dividends per
share		 Interim Non-
consoli
dated		 Yen 12.50 15.00 20
Year–end Non-
consoli
dated		 Yen 14.50 20.00 22
Total Non-
consoli
dated		 Yen 27.00 35.00 42
Community Number of
participants
in Bio Adventure activities		 　 Non-
consoli
dated		 Persons 446 549 305
Amount of
community
investments*5		 　 Non-
consoli
dated		 ¥ million 955 764 704
  1. *1:
    The number of employees who left the organization during this reporting period / the total number of full-time employees at the end of the reporting period (including employees who leave the organization voluntarily or due to dismissal, retirement, or death in service).
  2. *2:
    As of June each year. The figures are for the Kyowa Kirin Group (domestic).
  3. *3:
    The plants and research laboratories in Japan of Kyowa Kirin, Kyowa Medex (excluded in 2018 due to deconsolidation), Kyowa Hakko Bio and Kyowa Pharma Chemical are covered until 2018. In 2019, all locations of Kyowa Kirin are covered
  4. *4:
    data is for April to March of the following year.
  5. *5:
    Excludes temporary investments including support for disaster-stricken areas.

Governance

You can see this table by scrolling horizontally.

Aspect Classification Items Scope Unit FY2017 FY2018 FY2019
Governance Structure of board of
directors		 Number of
directors		 Non-
consoli
dated		 Persons 8 7 8
Number of
outside directors		 Non-
consoli
dated		 Persons 2 2 3
Number of
woman directors		 Non-
consoli
dated		 Persons 1 1 1
Structure of board of
company auditors		 Number of
company auditors		 Non-
consoli
dated		 Persons 5 5 5
Number of
outside company
auditors		 Non-
consoli
dated		 Persons 3 3 3
Compensation of
directors 		Total*1 Non-
consoli
dated		 ¥ Million 391 373 373
Compensation of
statutory auditors		 Total*2 Non-
consoli
dated		 ¥ Million 26 26 26
Income taxes
paid		 In
Japan		 Consoli
dated		 ¥ billion - 61 203
Outside
Japan		 Consoli
dated		 ¥ billion - 28 24
  1. *1:
    Compensation of the members, excluding outsaide directors are covered.
  2. *2:
    Compensation of the members, excluding outside company auditors are covered.